HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eph Family Receptors (Eph Receptors)

A large family of receptor protein-tyrosine kinases that are structurally-related. The name of this family of proteins derives from original protein Eph (now called the EPHA1 RECEPTOR), which was named after the cell line it was first discovered in: Erythropoietin-Producing human Hepatocellular carcinoma cell line. Members of this family have been implicated in regulation of cell-cell interactions involved in nervous system patterning and development.
Also Known As:
Eph Receptors; Receptors, Eph; Receptors, Eph Family; EphA Receptors; EphB Receptor; EphB Receptors; Ephrin A Receptors; Ephrin B Receptor; Ephrin B Receptors; Ephrin Receptors; Receptor, Ephrin B; Receptors, EphB; Receptors, Ephrin; Receptors, Ephrin A; Eph Receptor Tyrosine Kinase
Networked: 313 relevant articles (7 outcomes, 19 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pasquale, Elena B: 14 articles (01/2015 - 08/2006)
2. Wang, Jiandong: 13 articles (01/2022 - 01/2008)
3. Chen, Jin: 12 articles (11/2016 - 02/2002)
4. Theocharis, Stamatios: 9 articles (02/2022 - 09/2011)
5. Kandpal, Raj P: 9 articles (01/2022 - 06/2004)
6. Janes, Peter W: 7 articles (01/2021 - 12/2011)
7. Alexandrou, Paraskevi: 6 articles (02/2022 - 09/2011)
8. Giaginis, Constantinos: 6 articles (02/2022 - 06/2010)
9. Scott, Andrew M: 6 articles (01/2021 - 02/2012)
10. Song, Xue-Jun: 6 articles (01/2020 - 09/2008)

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Prostatic Neoplasms (Prostate Cancer)
4. Liver Cirrhosis (Hepatic Cirrhosis)
5. Adenocarcinoma of Lung

Related Drugs and Biologics

1. Ephrins
2. Ephrin-A1 (Ephrin A1)
3. Phosphotransferases (Kinase)
4. Monoclonal Antibodies
5. Vaccines
6. Ligands
7. Eph Family Receptors (Eph Receptors)
8. Erythropoietin
9. Proteins (Proteins, Gene)
10. Tyrosine (L-Tyrosine)

Related Therapies and Procedures

1. Therapeutics
2. Spinal Injections
3. Immunotherapy
4. Molecular Targeted Therapy
5. Immunomodulation